Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GS1B
|
||||
Former ID |
DNC013681
|
||||
Drug Name |
1-(2-morpholinoethyl)-1H-indol-3-yl acetate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528907] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H20N2O3
|
||||
Canonical SMILES |
CC(=O)OC1=CN(C2=CC=CC=C21)CCN3CCOCC3
|
||||
InChI |
1S/C16H20N2O3/c1-13(19)21-16-12-18(15-5-3-2-4-14(15)16)7-6-17-8-10-20-11-9-17/h2-5,12H,6-11H2,1H3
|
||||
InChIKey |
WNJZFVIJUKGTLU-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [528907] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.